Literature DB >> 18019084

Efficacy of hyperbaric oxygen on survival of random pattern skin flap in diabetic rats.

T Zhang1, W Gong, Z Li, S Yang, K Zhang, D Yin, P Xu, T Jia.   

Abstract

OBJECTIVES: This study was designed to determine if hyperbaric oxygen improved random pattern skin flap survival in diabetic rats.
METHODS: Cranially-based, 4 x 10 cm dorsal skin flaps were raised in 38 diabetic rats induced by streptozocin (STZ). The animals were randomly divided equally into two groups. Group A was a control group observed in the room air and Group B was the experimental group, which received hyperbaric oxygen (HBO2) therapy. The HBO2 regimen consisted of 90 minutes of treatment with 100% O2 at 2.5 ATA (atmosphere absolute ATA) per day for 7 consecutive days. On the 7th postoperative day, we measured the necrotic flap area and the new growth number of capillary vessel and the granulation tissue thickness.
RESULTS: The percentage of necrosis flap area for group A was 50.5 +/- 10.5%; for group B it was 38.5 +/- 9.3%. The reduction in necrosis flap area was highly significant (p < 0.01) compared with controls. Also, new-growth capillary vessel and granulation tissue thickness were statistically different between the two groups.
CONCLUSIONS: The findings of this study demonstrated beneficial effects of HBO2 in improving diabetic rat dorsal skin flap survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18019084

Source DB:  PubMed          Journal:  Undersea Hyperb Med        ISSN: 1066-2936            Impact factor:   0.698


  9 in total

1.  Combination of vascular endothelial growth factor-loaded microspheres and hyperbaric oxygen on random skin flap survival in rats.

Authors:  Xue-Guan Xie; Mei Zhang; Yan-Kun Dai; Ming-Sheng Ding; Sheng-Dong Meng
Journal:  Exp Ther Med       Date:  2015-07-06       Impact factor: 2.447

2.  Hyperbaric oxygen therapy improves the effect of keloid surgery and radiotherapy by reducing the recurrence rate.

Authors:  Ke-Xin Song; Shu Liu; Ming-Zi Zhang; Wei-Zhong Liang; Hao Liu; Xin-Hang Dong; You-Bin Wang; Xiao-Jun Wang
Journal:  J Zhejiang Univ Sci B       Date:  2018 Nov.       Impact factor: 3.066

3.  Adipose-derived stem cells accelerate neovascularization in ischaemic diabetic skin flap via expression of hypoxia-inducible factor-1α.

Authors:  Weicheng Gao; Xing Qiao; Shaolin Ma; Lei Cui
Journal:  J Cell Mol Med       Date:  2011-12       Impact factor: 5.310

4.  Favorable effects of progesterone on skin random flap survival in rats.

Authors:  Lin Dingsheng; Liu Zengbing; Huang Dong
Journal:  Iran J Basic Med Sci       Date:  2016-11       Impact factor: 2.699

5.  Hyperbaric oxygen therapy can ameliorate the EMT phenomenon in keloid tissue.

Authors:  Mingzi Zhang; Shu Liu; Enling Guan; Hao Liu; Xinhang Dong; Yan Hao; Xin Zhang; Pengxiang Zhao; Xuehua Liu; Shuyi Pan; Youbin Wang; Xiaojun Wang; Yifang Liu
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

6.  Effects of hyperbaric oxygen therapy on wound healing in veterinary medicine: A pilot study.

Authors:  Débora Gouveia; Sara Bimbarra; Carla Carvalho; Ana Cardoso; Óscar Gamboa; Rute Teixeira; António Ferreira; Ângela Martins
Journal:  Open Vet J       Date:  2021-10-10

7.  Effects of hyperbaric oxygen and N-acetylcysteine in survival of random pattern skin flaps in rats.

Authors:  Fernando P da Rocha; Djalma J Fagundes; Jefferson A Pires; Fernanda Salim T da Rocha
Journal:  Indian J Plast Surg       Date:  2012-09

8.  Local injection of deferoxamine improves neovascularization in ischemic diabetic random flap by increasing HIF-1α and VEGF expression.

Authors:  Chen Wang; Yuanyuan Cai; Yun Zhang; Zhuyou Xiong; Guangzao Li; Lei Cui
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

9.  Effects of hyperbaric oxygen therapy on the expression levels of the inflammatory factors interleukin-12p40, macrophage inflammatory protein-1β, platelet-derived growth factor-BB, and interleukin-1 receptor antagonist in keloids.

Authors:  Yan Hao; Xinhang Dong; Mingzi Zhang; Hao Liu; Lin Zhu; Youbin Wang
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.